Recently, the Genesis-JC Medical Group achieved a significant milestone by successfully completing a Transcatheter Aortic Valve Replacement procedure using the Genesis Transcatheter Aortic Valve system for a patient with severe aortic valve insufficiency and mild calcification.
On July 23, 2023, the enrollment of all cases of coated blood flow guided dense mesh stent, sponsored by Sinomed Neurovita Technology Inc., were successfully completed under the guidance of Professor Zhang Hongqi of Neurosurgery, Xuanwu Hospital of Capital Medical University.
Another major milestone for domestically produced medical devices.
On January 27, 2022, the registration application of the innovative product "abdominal endoscopic surgery system" produced by Shanghai MicroPort MedBot (Group) Co., Ltd. was approved by the State Drug Administration.
![[Congratulations] Lux Valve, the world's first tricuspid valve interventional replacement product of Jenscare, has completed the confirmatory clinical trial enrollment and reached an important milestone](/static/upload/images/20220606/3f28fb18c48fa6b81d63396c711c1a2e.jpg)
On August 18, 2021, with the close cooperation of academician Hu Shengshou and Professor Pan Xiangbin of Fuwai Hospital of Chinese Academy of Medical Sciences, Lux Valve implantation was successfully completed for two patients with tricuspid regurgitation.
On July 7, 2021, the "intracranial thrombectomy stent" of Hunan Risconce Medical Technolo
On June 24, 2021, "Taurus elite® transcatheter aortic valve system"of Peijia Medical Technology Co., Ltd has been approved by NMPA, registration Certificate No: National Device Registration Approval No.20213130464, which indicates that China's transcatheter aortic valve replacement (TAVR) will fully enter the "recyclable era".
